Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo.
Saved in:
| Title: | Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo. |
|---|---|
| Authors: | Winterberg D; ALL-BFM Study Group, Department of Pediatrics I, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller Str. 3, Haus C, 24105 Kiel, Germany.; Department of Medicine II Christian-Albrechts, Division of Stem Cell Transplantation and Immunotherapy, Campus Kiel, University Kiel and University Hospital Schleswig-Holstein, 24105 Kiel, Germany., Lenk L; ALL-BFM Study Group, Department of Pediatrics I, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller Str. 3, Haus C, 24105 Kiel, Germany., Oßwald M; Department of Medicine II Christian-Albrechts, Division of Stem Cell Transplantation and Immunotherapy, Campus Kiel, University Kiel and University Hospital Schleswig-Holstein, 24105 Kiel, Germany., Vogiatzi F; ALL-BFM Study Group, Department of Pediatrics I, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller Str. 3, Haus C, 24105 Kiel, Germany., Gehlert CL; Department of Medicine II Christian-Albrechts, Division of Stem Cell Transplantation and Immunotherapy, Campus Kiel, University Kiel and University Hospital Schleswig-Holstein, 24105 Kiel, Germany., Frielitz FS; Institute for Social Medicine and Epidemiology, University of Lübeck, 23538 Lübeck, Germany., Klausz K; Department of Medicine II Christian-Albrechts, Division of Stem Cell Transplantation and Immunotherapy, Campus Kiel, University Kiel and University Hospital Schleswig-Holstein, 24105 Kiel, Germany., Rösner T; Department of Medicine II Christian-Albrechts, Division of Stem Cell Transplantation and Immunotherapy, Campus Kiel, University Kiel and University Hospital Schleswig-Holstein, 24105 Kiel, Germany., Valerius T; Department of Medicine II Christian-Albrechts, Division of Stem Cell Transplantation and Immunotherapy, Campus Kiel, University Kiel and University Hospital Schleswig-Holstein, 24105 Kiel, Germany., Trauzold A; Institute for Experimental Cancer Research, Christian-Albrechts-University Kiel, 24104 Kiel, Germany., Peipp M; Department of Medicine II Christian-Albrechts, Division of Stem Cell Transplantation and Immunotherapy, Campus Kiel, University Kiel and University Hospital Schleswig-Holstein, 24105 Kiel, Germany., Kellner C; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, LMU University Hospital Munich, 81377 Munich, Germany., Schewe DM; ALL-BFM Study Group, Department of Pediatrics I, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller Str. 3, Haus C, 24105 Kiel, Germany. |
| Source: | Journal of clinical medicine [J Clin Med] 2021 Jun 15; Vol. 10 (12). Date of Electronic Publication: 2021 Jun 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
